溶瘤腺病毒的研究进展
被引量:1
Progress in the Study of Oncolytic Adenouiruses
出处
《肿瘤防治研究》
CAS
CSCD
2004年第4期243-245,共3页
Cancer Research on Prevention and Treatment
基金
国家"八六三"计划生物和现代农业技术研究基金资助项目 (2 0 0 1AA2 17171)
广东省自然科学基金重点项目 (0 130 72 )
参考文献20
-
1[1]Hemminki A, Alvarez RD. Adenoviruses in oncology: a viable option?[J]. BioDrugs, 2002,16(2):77-87.
-
2[2]Bischoff JR, Kirn DH, Williams A. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells[J]. Science,1996,274(5286):373-376.
-
3[3]Ries S, Korn WM. ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus[J]. Br J Cancer, 2002,86(1):5-11.
-
4[4]Caspari T. How to activate p53[J]. Curr Biol, 2000,10(8):315-317.
-
5[5]Sherr CJ, Weber JD. The ARF/p53 pathway[J]. Curr Opin Genet Dev, 2000,10(1):94-99.
-
6[6]Rogulski KR, Freytag SO, Zhang K. In vivo antitumor activity of ONYX-015 is influenced by p53 status and is augmented by radiotherapy[J]. Cancer Res, 2000,60(5):1193-1196.
-
7[7]Ganly I, Kim YT, Hann B. Replication and cytolysis of an E1B-attenuated adenovirus in drug-resistant ovarian tumour cells is associated with reduced apoptosis[J]. Gene Ther, 2001,8(5):369-375.
-
8[8]Turnell AS, Grand RJ, Gallimore PH. The replicative capacities of large E1B-null group A and group C adenoviruses are independent of host cell p53 status[J]. J Virol, 1999,73(3):2074-2083.
-
9[9]Ries SJ, Brandts CH, Chung AS. Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015) [J]. Nat Med,2000,6(10):1128-1133.
-
10[10]Mulvihill S, Warren R, Venook A. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial[J]. Gene Ther,2001,8(4):308-315.
同被引文献5
-
1Xin Yuan Liu~(1,2) ~1Institute of Biochemistry and Cell Biology,Shanghai Institutes for Biological Sciences,Chinese Academy of Sciences,320 Yue Yang Road,Shanghai 200031,China,~2Xinyuan Institute of Medicine and Biotechnology,School of Life Science,Zhejiang Sci-Tech University,Hangzhou 310018,China.Targeting Gene-Virotherapy of Cancer and its prosperity[J].Cell Research,2006,16(11):879-886. 被引量:32
-
2熊壮,王建华.溶瘤病毒在肝癌介入治疗中的应用[J].介入放射学杂志,2007,16(3):206-208. 被引量:9
-
3周晓曦,李钦璐,黄闪,姜利军,周剑峰,曹阳.静脉输注新型溶瘤腺病毒在体内复制活性与抑瘤的关系[J].现代生物医学进展,2012,12(19):3624-3627. 被引量:1
-
4谭晓华.溶瘤腺病毒肿瘤靶向治疗:从实验室到临床[J].中国肿瘤生物治疗杂志,2012,19(6):569-576. 被引量:10
-
5ZILAIZHANG,WEIGUOZOU,CHUNXIALUO,BINGHUALI,JINHUIWANG,LANYINGSUN,QIJUNQIAN,XINYUANLIU.An armed oncolytic adenovirus system,ZD55-gene,demonstrating potent antitumoral efficacy[J].Cell Research,2003,13(6):481-489. 被引量:46
二级引证文献4
-
1马步云,何婉婉,周立,王毅刚.癌症靶向基因-病毒ZD55-XAF1抗肝癌移植瘤的生长及其安全性研究[J].中国生物工程杂志,2014,34(1):15-20. 被引量:2
-
2赵文超,金鑫,郑明华,牛天力,郑骏年.溶瘤腺病毒靶向治疗恶性肿瘤研究进展[J].现代肿瘤医学,2014,22(10):2499-2502.
-
3郭婉,金槿,肖伯端,王毅刚,周秀梅.基于溶瘤腺病毒抗肿瘤免疫治疗的前景与展望[J].中国细胞生物学学报,2018,40(6):1016-1022. 被引量:3
-
4王淼,倪婷婷,伍生军,赵云,宋建臣,董亮,薛书江.猪附红细胞体ENO基因重组腺病毒穿梭质粒的构建及真核表达[J].中国畜牧兽医,2018,45(8):2113-2118. 被引量:3
-
1王顺和,郑杰,崔湘琳,王洁良,吴秉铨.裸鼠自发性肿瘤病理学及免疫组织化学研究[J].实验动物科学与管理,1998,15(3):10-12.
-
2王顺和.裸鼠自发性肿瘤病理形态及免疫组化研究[J].重庆医科大学学报,1997,22(4):290-292.
-
3刘政,薄志坚,张莲英,刘君,李云,邹桂香.蝮蛇抗栓酶对大鼠自发性肿瘤作用的研究[J].癌变.畸变.突变,1995,7(4):218-218.
-
4黄培根,沈淑静,莫梅英,李飞虹.裸小鼠繁殖群自发性肿瘤发病情况的研究[J].湛江医学院学报,1993,11(1):5-8. 被引量:1
-
5冯怡.小鼠子宫自发性神经纤维样平滑肌肉瘤的病理学观察[J].上海实验动物科学,2001,21(2):98-99.
-
6李世宁,阮思蓓,朱小霞,张翠薇,熊小明,倪江涛,张元,唐明希.C6细胞肝与脾原位接种模型的建立及比较[J].临床与实验病理学杂志,2013,29(3):280-283. 被引量:5
-
7齐旭,周伊,王一理,马军,闫晓彩,韩俊宏,来宝长,尚宁宽,耿宜萍,司履生.同系细胞瘤苗对低免疫原性小鼠黑色素瘤治疗作用的研究[J].中国肿瘤生物治疗杂志,2002,9(1):60-61. 被引量:5
-
8牟霞,陆洪光,吴承龙,余德厚,程波,汪宇.B16小鼠皮肤恶性黑素瘤模型的建立[J].中华皮肤科杂志,2004,37(10):613-613. 被引量:7
-
9内分泌腺肿瘤[J].国外科技资料目录(医药卫生),2002(5):144-144.
-
10朱大和,S Ivankovic,张韵凤.氧化铂对实验性大鼠致癌作用的进一步探讨[J].同济医科大学学报,2001,30(6):525-526.